FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
SAGE Therapeutics (NASDAQ: SAGE) reported Q2 EPS of ($1.88), $0.21 worse than the analyst estimate of ($1.67).
For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.
... More
